Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip

Moleculin Biotech Inc. (NASDAQ: MBRX) Listen to this Section


$2.42
+0.1850 ( +8.30% ) 76.9K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data


Open


$2.42

Previous close


$2.23

Volume


76.9K

Market cap


$6.25M

Day range


$1.48 - $2.44

52 week range


$1.48 - $15.75

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 42 May 14, 2024
8-k/a 8K-related 16 May 13, 2024
8-k 8K-related 16 May 13, 2024
10-q Quarterly Reports 54 May 10, 2024
8-k 8K-related 16 May 09, 2024
8-k 8K-related 17 May 08, 2024
8-k 8K-related 56 May 07, 2024
8-k 8K-related 16 May 07, 2024
8-k 8K-related 17 May 02, 2024
10-k/a Quarterly Reports 16 Apr 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.